1. Home
  2. MPAA vs CGEN Comparison

MPAA vs CGEN Comparison

Compare MPAA & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MPAA
  • CGEN
  • Stock Information
  • Founded
  • MPAA 1968
  • CGEN 1993
  • Country
  • MPAA United States
  • CGEN Israel
  • Employees
  • MPAA N/A
  • CGEN N/A
  • Industry
  • MPAA Auto Parts:O.E.M.
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MPAA Consumer Discretionary
  • CGEN Health Care
  • Exchange
  • MPAA Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • MPAA 143.3M
  • CGEN 142.8M
  • IPO Year
  • MPAA 1994
  • CGEN 2000
  • Fundamental
  • Price
  • MPAA $7.91
  • CGEN $1.53
  • Analyst Decision
  • MPAA
  • CGEN Strong Buy
  • Analyst Count
  • MPAA 0
  • CGEN 1
  • Target Price
  • MPAA N/A
  • CGEN $4.00
  • AVG Volume (30 Days)
  • MPAA 59.5K
  • CGEN 490.9K
  • Earning Date
  • MPAA 02-07-2025
  • CGEN 11-12-2024
  • Dividend Yield
  • MPAA N/A
  • CGEN N/A
  • EPS Growth
  • MPAA N/A
  • CGEN N/A
  • EPS
  • MPAA N/A
  • CGEN 0.02
  • Revenue
  • MPAA $739,413,000.00
  • CGEN $59,852,000.00
  • Revenue This Year
  • MPAA $8.91
  • CGEN $57.27
  • Revenue Next Year
  • MPAA $6.99
  • CGEN N/A
  • P/E Ratio
  • MPAA N/A
  • CGEN $85.40
  • Revenue Growth
  • MPAA 5.20
  • CGEN 698.03
  • 52 Week Low
  • MPAA $4.36
  • CGEN $1.35
  • 52 Week High
  • MPAA $10.40
  • CGEN $3.03
  • Technical
  • Relative Strength Index (RSI)
  • MPAA 58.43
  • CGEN 44.44
  • Support Level
  • MPAA $7.41
  • CGEN $1.44
  • Resistance Level
  • MPAA $8.17
  • CGEN $1.68
  • Average True Range (ATR)
  • MPAA 0.37
  • CGEN 0.09
  • MACD
  • MPAA -0.06
  • CGEN -0.00
  • Stochastic Oscillator
  • MPAA 48.08
  • CGEN 33.33

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a us-based manufacturer, remanufacturer, and distributor of aftermarket automotive and light truck applications. It manufactures and distributes heavy-duty truck and industrial and agricultural application parts. It produces starter engines, alternators, hub assemblies, bearings, and master cylinders. The company supplies its products to the automotive aftermarket either under its own brands, as part of a private-label service, or to warranty replacement programs of automobile manufacturers. It primarily sells rotating electrical products, wheel hub products, brake master cylinders products in the us, of which a majority of the revenue is derived from the sales of rotating electrical products.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: